Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGN-00101 (HspE7) Immunotherapy in CIN III
NCT00075569Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Mar 2004
- Primary completion
- Aug 2005
- Modality
- Vaccines & Immunotherapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of verpasep caltespen in cervical intraepithelial neoplasia (CIN), sponsored by Albert Einstein College of Medicine. Started Mar 2004; status: completed.
02
Drugs
verpasep caltespen
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00075569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075569.